EASL encourages healthcare professionals to share the EASL supported COVID-Hep registry among its networks. The registry was launched at the University of Oxford, UK in March 2020, to collect data on patients, with liver disease at any stage or liver…
A review published in Liver International journal summarises the characteristics and mechanism of liver injury caused by three highly pathogenic human coronavirus infections: severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory syndrome coronavirus (MERS‐CoV), and SARS‐CoV‐2 infection (referred to…
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and after taking extensive advice, we have decided on…
On 2 March 2020, the U.S. Preventive Services Task Force published a final recommendation statement on screening for hepatitis C virus (HCV) infection in adolescents and adults. It recommends screening all adults ages 18 to 79 for hepatitis C, regardless…
Following the initiative of other leading scientific journals, we believe that it is timely, important, and appropriate to share as soon as possible with our Journal of Hepatology readers all information available on the possible impact of COVID-19 (coronavirus) on…
Europe’s Beating Cancer Plan needs a thorough prevention pillar to tackle challenges common to all non-communicable diseases (NCDs), reads a statement by 30+ health organisations. NCDs, such as cardiovascular disease, cancer, respiratory diseases and diabetes, undermine people’s health and well-being,…
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the European Association for the Study of the Liver,…
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease. This year’s postgraduate course at the International Liver…
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker, who died on 19 November 2019 at the age of 59. Prof. von Weizsäcker was an expert for gastroenterology, hepatology, oncology, and infectiology at Schlosspark Clinic in…
We’re pleased to announce the launch of our improved multi-disciplinary eLearning hub, EASL Campus, designed to help you develop your hepatology and liver-related disease knowledge through a variety of open-access, high quality and interactive resources tailored to your specialism and…